|
Volumn 13, Issue 9, 2001, Pages 1073-1076
|
Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?
|
Author keywords
Azathioprine; Crohn s disease; Inflammatory bowel disease; Neutropenia; Ulcerative colitis
|
Indexed keywords
AZATHIOPRINE;
MERCAPTOPURINE;
THIOPURINE METHYLTRANSFERASE;
ADULT;
AGED;
ARTICLE;
CELL MIGRATION;
COLON CROHN DISEASE;
DRUG EFFECT;
DRUG EFFICACY;
ENTERITIS;
FEMALE;
FOLLOW UP;
HUMAN;
LAMINA PROPRIA;
MAJOR CLINICAL STUDY;
MALE;
NEUTROPENIA;
NEUTROPHIL;
PANCYTOPENIA;
PRIORITY JOURNAL;
RELAPSE;
REMISSION;
SURVIVAL;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
AZATHIOPRINE;
COHORT STUDIES;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFLAMMATORY BOWEL DISEASES;
LONG-TERM CARE;
MALE;
MIDDLE AGED;
NEUTROPENIA;
PROBABILITY;
PROGNOSIS;
RECURRENCE;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
STATISTICS, NONPARAMETRIC;
TREATMENT OUTCOME;
|
EID: 0034812896
PISSN: 0954691X
EISSN: 14735687
Source Type: Journal
DOI: 10.1097/00042737-200109000-00013 Document Type: Article |
Times cited : (26)
|
References (9)
|